CADL – candel therapeutics, inc. (US:NASDAQ)

News

Loss-Making Candel Therapeutics, Inc. (NASDAQ:CADL) Expected To Breakeven In The Medium-Term [Yahoo! Finance]
Candel Therapeutics (NASDAQ:CADL) had its "overweight" rating reaffirmed by analysts at Stephens. They now have a $15.00 price target on the stock.
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025 [Yahoo! Finance]
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
Candel Therapeutics (NASDAQ:CADL) was downgraded by analysts at Wall Str
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com